Climate change is expanding the range of mosquito-borne diseases such as yellow fever, making outbreaks more frequent, unpredictable, and difficult to contain. At a roundtable hosted and sponsored by Sanofi, global health leaders and innovators discussed how innovation can transform the way yellow fever vaccines are produced and delivered to ensure faster and more sustainable access to vaccines.
The agent mentioned here is investigational and has not been approved by the U.S. Food and Drug Administration, or FDA, or any other regulatory agency worldwide. No conclusions regarding safety and efficacy should be drawn for such agent.
Visit Sanofi’s website to learn more.